Meristem Family Wealth’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,425
Closed -$248K 353
2021
Q4
$248K Sell
1,425
-5
-0.3% -$834 0.02% 331
2021
Q3
$237K Buy
1,430
+46
+3% +$7.92K 0.02% 356
2021
Q2
$249K Hold
1,384
0.04% 278
2021
Q1
$267K Sell
1,384
-2
-0.1% -$385 0.05% 192
2020
Q4
$280K Hold
1,386
0.06% 181
2020
Q3
$291K Buy
1,386
+5
+0.4% +$1.11K 0.07% 142
2020
Q2
$303K Hold
1,381
0.08% 138
2020
Q1
$239K Sell
1,381
-10
-0.7% -$1.65K 0.07% 153
2019
Q4
$214K Hold
1,391
0.05% 180
2019
Q3
$211K Buy
+1,391
New +$220K 0.06% 179

Other funds holding CLX

Meristem Family Wealth's CLX Position: Q1 2022 in Review

Meristem Family Wealth sold out of Clorox (CLX) in Q1 2022, closing a stake of 1,425 shares — an estimated $248K sold.

Meristem Family Wealth first reported a position in CLX in Q3 2019 and held it in 10 quarters. The position peaked at $303K in Q2 2020. 1,096 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • Meristem Family Wealth reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
  • Meristem Family Wealth sold 1,425 Clorox shares in Q1 2022, an estimated $248K.
  • Meristem Family Wealth first reported a position in Clorox in Q3 2019 and held it in 10 quarters.
  • Meristem Family Wealth's Clorox position peaked at $303K in Q2 2020.
  • 1,096 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Meristem Family Wealth's 13F filing for Q1 2022, filed 11 May 2022.